US 2001/0018448 A1 · Medicament

Abstract

The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for the treatment of haemorrhagic stroke.

Claims11

Dependent claims

A method of treating haemorrhagic stroke in a mammal which comprises administering to a subject in need thereof an effective amount of an angiotensin II receptor antagonist.

Dependencies are inferred from the claim text.

Facts

Application

09/805,474Filed 13 Mar 2001

Priority

GB 9027199.014 Dec 1990

Published

30 Aug 2001

Term ends

Not estimatedThe source records don’t support an estimate.

Classification3 codes

A61K 31/41
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having five-membered rings with two or more ring hetero atoms, at least…
A61K 31/415
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: 1,2-Diazoles
A61K
Medicines and medical preparations

Family

Application08/074,807Continuation · filed 10 Jun 1993

Application08/074,807A 371 of international · filed 10 Jun 1993

Application08/304,904Continuation · filed 13 Sep 1994

Application08/614,226Continuation · filed 12 Mar 1996

Application08/775,344Continuation · filed 3 Jan 1997

Application08/940,768Continuation · filed 30 Sep 1997

Application09/153,527Continuation · filed 15 Sep 1998

Application09/272,775Continuation · filed 29 Mar 1999

Application09/603,719Continuation · filed 27 Jun 2000

Application09/805,474Continuation · filed 13 Mar 2001

US 2001/0018448 A1This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for the treatment of haemorrhagic stroke.

Facts

Application

09/805,474Filed 13 Mar 2001

Priority

GB 9027199.014 Dec 1990

Published

30 Aug 2001

Term ends

Not estimatedThe source records don’t support an estimate.

Classification3 codes

A61K 31/41
Having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins: having five-membered rings with two or more ring hetero atoms, at least…
A61K 31/415
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: 1,2-Diazoles
A61K
Medicines and medical preparations

Family

Application08/074,807Continuation · filed 10 Jun 1993

Application08/074,807A 371 of international · filed 10 Jun 1993

Application08/304,904Continuation · filed 13 Sep 1994

Application08/614,226Continuation · filed 12 Mar 1996

Application08/775,344Continuation · filed 3 Jan 1997

Application08/940,768Continuation · filed 30 Sep 1997

Application09/153,527Continuation · filed 15 Sep 1998

Application09/272,775Continuation · filed 29 Mar 1999

Application09/603,719Continuation · filed 27 Jun 2000

Application09/805,474Continuation · filed 13 Mar 2001

US 2001/0018448 A1This patent

From the US filing history. Foreign family members aren’t listed.

Medicament

Life of this patent

Abstract

Claims11

Medicament

Life of this patent

Abstract

Claims11